Turn Financial Statements From 2010 to 2025

Stocks . USA . 
Stock . Turn Therapeutics Common
TTRX Stock   3.71  0.57  18.15%   
Turn Therapeutics' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Turn Therapeutics' valuation are provided below:
Turn Therapeutics Common does not presently have any fundamental trend indicators for analysis.
Check Turn Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Turn Therapeutics' main balance sheet or income statement drivers, such as Net Interest Income of 24.5 K, Interest Income of 24.5 K or Depreciation And Amortization of 50.3 K, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 0.0. Turn financial statements analysis is a perfect complement when working with Turn Therapeutics Valuation or Volatility modules.
  
Build AI portfolio with Turn Stock
Check out the analysis of Turn Therapeutics Correlation against competitors.

Turn Therapeutics Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets2.2 M2 M2 M
Slightly volatile
Short and Long Term Debt Total80.4 K121 K34.6 K
Slightly volatile
Other Current Liabilities622.5 K667.3 K487.2 K
Slightly volatile
Total Current Liabilities658.7 K707.9 K514 K
Slightly volatile
Property Plant And Equipment Net84.5 K120.5 K41.9 K
Slightly volatile
Cash821.4 K872.6 K1.1 M
Slightly volatile
Non Current Assets Total969.5 K951 K830.3 K
Slightly volatile
Non Currrent Assets Other6.9 K7.7 K8.4 K
Slightly volatile
Cash And Short Term Investments821.4 K872.6 K1.1 M
Slightly volatile
Liabilities And Stockholders Equity2.2 M2 M2 M
Slightly volatile
Non Current Liabilities Total1.6 M1.5 M1.5 M
Slightly volatile
Capital Lease Obligations80.4 K121 K34.6 K
Slightly volatile
Other Current Assets135.4 K225.3 K40.8 K
Slightly volatile
Other Stockholder Equity20.1 M19 M17.8 M
Slightly volatile
Total Liabilities2.3 M2.2 M2 M
Slightly volatile
Property Plant And Equipment Gross84.5 K120.5 K41.9 K
Slightly volatile
Total Current Assets919.9 K1.1 M1.2 M
Slightly volatile
Capital Stock1.5 K1.3 K1.3 K
Slightly volatile
Net Working Capital440.8 K390 K675 K
Slightly volatile
Short Term Debt36.2 K40.7 K26.8 K
Slightly volatile
Intangible Assets875.5 K821.9 K779.8 K
Slightly volatile
Common Stock1.5 K1.3 K1.3 K
Slightly volatile

Turn Therapeutics Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Net Interest Income24.5 K28.7 K17.2 K
Slightly volatile
Interest Income24.5 K28.7 K17.2 K
Slightly volatile
Depreciation And Amortization50.3 K47.5 K44.5 K
Slightly volatile
Selling General Administrative1.5 M1.6 M2.2 M
Slightly volatile
Other Operating Expenses1.6 M1.8 M2.2 M
Slightly volatile
Research Development139.4 K246 K30.6 K
Slightly volatile
Total Operating Expenses1.6 M1.8 M2.2 M
Slightly volatile
Reconciled Depreciation50.3 K47.5 K44.5 K
Slightly volatile
Total Other Income Expense Net24.5 K28.7 K17.2 K
Slightly volatile

Turn Therapeutics Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation397.2 K352.8 K607.1 K
Slightly volatile
Begin Period Cash Flow1.3 M1.2 M2 M
Slightly volatile
Depreciation50.3 K47.5 K44.5 K
Slightly volatile
Other Non Cash Items5.1 K8.7 K1.4 K
Slightly volatile
Capital Expenditures79.1 K99.5 K49.9 K
Slightly volatile
Issuance Of Capital Stock908.8 K1.2 M566.3 K
Slightly volatile
Total Cash From Financing Activities908.8 K1.2 M566.3 K
Slightly volatile
End Period Cash Flow821.4 K872.6 K1.1 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Capex To Depreciation1.242.0951.0911
Slightly volatile
Income Quality0.550.76980.6084
Pretty Stable
EV To Operating Cash Flow0.770.55210.8167
Slightly volatile
EV To Free Cash Flow0.730.51450.789
Slightly volatile
Intangibles To Total Assets0.310.40120.379
Slightly volatile
Net Debt To EBITDA0.520.42960.506
Slightly volatile
Current Ratio2.21.55092.3815
Slightly volatile
Debt To Assets0.0620.05910.0185
Slightly volatile
Enterprise Value Over EBITDA0.520.42960.506
Slightly volatile
Ebt Per Ebit1.090.9840.9986
Slightly volatile
Quick Ratio2.21.55092.3815
Slightly volatile
Cash Ratio2.01.23262.3119
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.841.07311.0227
Slightly volatile
Enterprise Value Multiple0.520.42960.506
Slightly volatile
Debt Ratio0.0620.05910.0185
Slightly volatile

About Turn Therapeutics Financial Statements

Turn Therapeutics investors use historical fundamental indicators, such as Turn Therapeutics' revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Turn Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
DDDupont De Nemours
CRDOCredo Technology Group
GOOGAlphabet Inc Class C

Additional Tools for Turn Stock Analysis

When running Turn Therapeutics' price analysis, check to measure Turn Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Turn Therapeutics is operating at the current time. Most of Turn Therapeutics' value examination focuses on studying past and present price action to predict the probability of Turn Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Turn Therapeutics' price. Additionally, you may evaluate how the addition of Turn Therapeutics to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2025 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY